The initiation of coverage by Stephens & Co. with an Equal-Weight rating suggests a neutral outlook for Alignment Healthcare. The price target of $9 indicates the analyst's expectation of the stock's future performance. This could influence investor sentiment and potentially impact the stock's price in the short term.